Chinese e-commerce giant JD has reported that sales of vitamin C dietary supplements on its platform were up five-fold, after the announcement of the novel coronavirus.
It is no surprise that Chinese retailers and suppliers are reporting a surge in demand for vitamin C supplements. A few weeks ago, a medical team from the Second Affiliated Hospital of Xi’an Jiaotong University in China reported the successful treatment of coronavirus patients with vitamin C.
In a press release posted on the hospital website, the team describes how patients suffering from severe coronary pneumonia, a potentially fatal complication of the new coronavirus COVID-19, have recovered after being treated with high doses of the vitamin. The medical team recommend that for critically ill patients and those with severe neonatal pneumonia, vitamin C treatment should be initiated as soon as possible after admission to hospital.
Significantly, the press release acknowledges that early application of vitamin C can have a strong antioxidant effect, reduce inflammatory responses, and improve endothelial function. It also describes how numerous studies have shown the dose of vitamin C used has a lot to do with the treatment’s effect. The medical team say their past experience shows that high-dose vitamin C can not only improve antiviral levels, but more importantly can prevent and treat acute lung injury and acute respiratory distress.
To learn more about this important development, read this article on our website.